ArticleJournal of inflammation research2022

PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer.

Xinwei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.